生理期および新生児の危険因子および構造的肺異常は,重度のブロンコ肺不形成症の乳児における低酸素性チャレンジテストの失敗を予測する
Kishan D Tsang1,2, Daan Caudri1,3, Citta Zaat1
1Department of Pediatrics, Division of Respiratory Medicine and Allergology, Erasmus MC Sophia Children's Hospital University Medical Center, Rotterdam, the Netherlands.
Pediatric pulmonology
|February 18, 2026
まとめ
長時間の酸素療法と肺の異常は,重度の支障管肺不形成症の乳児における低酸素性チャレンジテストの失敗を予測する. これらの要因は,BPDにおける構造的および機能的障害の両方の臨床的関連性を強調しています.
科学分野:
- ネオナトロジーの新生児科
- 小児肺病学について
- メディカルイマージング (医学イメージング)
背景:
- 重度の支柱肺不形成症 (BPD) の乳児は,低酸素血症のリスクに直面し,しばしば低酸素チャレンジテスト (HCT) に失敗します.
- 重度のBPDにおけるHCTアウトカムに関する臨床的要因と肺構造の予測的価値は不明である.
研究 の 目的:
- 重度のBPDの早産児におけるHCT不全の臨床的および構造的予測要因を特定する.
- 肺イメージングスコアとHCTアウトカムとの関連性を評価する.
主な方法:
- 妊娠32週未満の,重度のBPDの早産児に関する前向きなコホート研究.
- 胸部CTスキャンでは,PRAGMA-BPDスコアリングを使用して6ヶ月で肺の構造異常を定量化しました.
- 低毒性チャレンジテスト (HCT) は酸素飽和度の維持を評価し,ロジスティック回帰はHCTの失敗の予測要因を特定した.
主要な成果:
- 156人の乳児の28.8%がHCTに失敗した.
- 補充酸素療法の長期間とより高いPRAGMA-BPDスコアは,HCTの失敗を独立して予測した.
- パテントダクトス動脈と肺高血圧は,単変数解析でHCTの失敗と関連していました.
結論:
- 補充酸素療法の持続時間と構造的肺異常は,重度のBPDにおけるHCT不全の独立した予測因子である.
- 研究結果は,重度のBPDの管理における構造的および機能的障害の両方の臨床的重要性を強調しています.
キーワード:
bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia bronchopulmonary dysplasia is located located located located located located located located located located located located located located located located located located located located located located located located located located located located located located located located located located located located located located within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within within withinコンピュータートモグラフィーです.低酸素性チャレンジテストテスト時期が早かったこと.早期出産に関連した肺疾患関連する概念動画
Acute Respiratory Failure-II
1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-I
1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Pulmonary Cycle: Exhalation
3.9K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
3.9K
Acute Respiratory Failure-III
966
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
966
Breathing
64.8K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
64.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.8K


